Why Choose Omron
All Products are Clinically Validated
We ensure all Omron Blood Pressure Monitors are clinically validated and meet the highest standards of precision and reliability from trusted organisations such as AAMI or ESH.
Intellisense® Technology for Comfort & Accuracy
Intellisense® Technology, available in all Omron Blood Pressure Monitors, can automatically personalise the cuff inflation just for you to ensure fast, accurate and more comfortable measurements.
Trusted Brand from Japan with Over 50-Years Experience in Home Blood Pressure Monitors
Our blood pressure monitors are available in over 130 countries/regions and used worldwide by millions of people and healthcare professionals. We offer a wide range of products to suit differing needs and keep innovating new technology and solutions in the heart healthcare field.
What is Clinical Validation?
How do we know if a blood pressure monitor (BPM) is accurate? The best assurance for accuracy of a BPM is Clinical Validation.
A Clinically Validated BPM is one which has been evaluated by an independent organisation and tested against, as well as met the stringent requirements as set out by international organisations such as Association for the Advancement of Medical Instrumentation Standard (AAMI) and European Society for Hypertension (ESH).
|Type||Product Models ^||Clinically Validated According to Standards of||
|Association for the Advancement of Medical Instrumentation Standard (AAMI)||European Society of Hypertension International Protocol (ESH)|
|Upper Arm Blood Pressure Monitor||HEM-7120-AP||✔||✔||2||B|
|Wrist Blood Pressure Monitor||HEM-6121-AP||✔||16||D|
|Professional Blood Pressure Monitor||HEM-9200T||✔||21||C|
A. Hakuo Takahashi. Validation of Home Blood Pressure-monitoring Devices Omron EVOLV (HEM-7600T-E), HEM-9210T, and M3 Comfort (HEM-7134-E) According to European Society of Hypertension International Protocol (ESH-IP) Revision 2010. J. Clin. Physiol., Vol. 49, No. 1, 2019. Original Paper: Validation of the Omron EVOLV (HEM-7600T-E) upper arm blood pressure monitor, in oscillometry mode, for self measurement in a general population, according to the European Society of Hypertension International Protocol Revision 2010 [Internet]. Dublin: dabl Educational Trust; 2016 November 28.
B. Hakuo Takahashi, Masamichi Yoshika and Toyohiko Yokoi. Validation of three automatic devices for the self-measurement of blood pressure according to the European Society of Hypertension International Protocol revision 2010: the Omron HEM-7130, HEM-7320F, and HEM-7500F. Blood Pressure Monitoring 2015, 20:92–97. [Internet]. Dublin: dablEducational Trust; 2014 Jan 22. 4 p.
C. Hakuo Takahashi, Masamichi Yoshika and Toyohiko Yokoi. Validation of two automatic devices for the self-measurement of blood pressure according to the ANSI /AA MI/IS O81060-2:2009 guidelines: the Omron BP765 (HEM-7311-ZSA ) and the Omron BP760N (HEM-7320-Z). Vascular Health and Risk Management 2015:11 49–53.
D. Hakuo Takahashi, Masamichi Yoshika and Toyohiko Yokoi. Validation of Omron RS8, RS6, and RS3 home blood pressure monitoring devices, in accordance with the European Society of Hypertension International Protocol revision 2010. Vascular Health and Risk Management 2013:9 265–272
E. Kanako Saito, Yukiko Hishiki, and Hakuo Takahashi. Validation of two automatic devices, Omron HEM-6232T and HEM-6181, for self-measurement of blood pressure at the wrist according to the ANSI/AAMI/ISO 81060-2:2013 protocol and the European Society of Hypertension International Protocol revision 2010. Vascular Health and Risk Management. 2019;15:47-55
F. Alpert BS Blood Press Monit. 2017 Jun;22(3):166-168. Validation of the Omron HEM-9210T by the ANSI/AAMI/ISO 81060-2: 2013 with two novel cuffs: wide-range and extra-large.
G. Grover-Páez F1, Cardona-Muñoz EG, Cardona-Müller D, Guzmán-Saldívar VH, Rodríguez-De la Cerda M, Jiménez-Cázarez MB, Totsuka-Sutto SE, Alanis-Sánchez GA, Ramos-Becerra CG. Validation of the Omron HEM-7320-LA, upper arm blood pressure monitor with Intelli Wrap Technology Cuff HEM-FL1 for self-measurement and clinic use according to the European Society of Hypertension International Protocol revision 2010 in the Mexican population.